IPONOVA — India's IPO Intelligence Platform

Aurobindo Pharma Ltd Buyback 2026

Method: Tender Offer · Status: Tender Open

Buyback Price: ₹1,474.00 · CMP: ₹1,386.20 · Premium: 6.33%

Buyback Size: ₹800.00 Cr · Shares: 5,423,728

Record Date: 17 Apr 2026 · Tender Open: 23 Apr 2026 · Tender Close: 29 Apr 2026 · Payment:

Small Shareholder Reservation: 15.00%

Frequently Asked Questions

What is the Aurobindo Pharma Ltd buyback price?

The Aurobindo Pharma Ltd buyback price is ₹1,474.00 per share. The buyback uses the Tender Offer method.

What is the record date for Aurobindo Pharma Ltd buyback?

The record date for the Aurobindo Pharma Ltd buyback is 17 Apr 2026. Shareholders holding shares as of this date are eligible to participate.

When does the Aurobindo Pharma Ltd buyback tender window open and close?

The Aurobindo Pharma Ltd buyback tender window opens on 23 Apr 2026 and closes on 29 Apr 2026. Payment is scheduled for within 7 working days of acceptance, per SEBI Buyback Regulations.

What is the acceptance ratio for Aurobindo Pharma Ltd buyback?

Acceptance ratios for the Aurobindo Pharma Ltd buyback will be published once the tender window closes and shares are accepted.

What is the premium on Aurobindo Pharma Ltd buyback over CMP?

The Aurobindo Pharma Ltd buyback price of ₹1,474.00 is at a premium of 6.33% over the current market price of ₹1,386.20.

How can I participate in the Aurobindo Pharma Ltd buyback?

To participate in the Aurobindo Pharma Ltd buyback, you must hold shares as of the record date (17 Apr 2026) and tender your shares through your broker during the tender window (23 Apr 2026 to 29 Apr 2026). Use the IPONOVA buyback calculator to estimate your returns and acceptance.

Disclaimer: IPONOVA is an information platform only. We are not SEBI-registered investment advisors. All data is presented for educational and informational purposes and is sourced from publicly available filings on BSE, NSE and SEBI. Investment in securities market is subject to market risks. Read all related documents carefully before investing. Past performance is not indicative of future returns. Please consult a SEBI-registered investment advisor before making any investment decisions.